Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11708412 Methods for treating hematologic cancers

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Date of Patent

July 25, 2023

0

Patent Application Number

167247590

Date Filed

December 23, 2019

0

Patent Citations

US Patent 9333256 Methods related to TIM 3, a Th1-specific cell surface molecule, for activating antigen presenting cells

0

US Patent 10851165 Antibody molecules to PD-L1 and methods of treating cancer

0

US Patent 10981990 Antibody molecules to TIM-3 and uses thereof

0

US Patent 11344620 Combination therapies

0

US Patent 7101550 PD-1, a receptor for B7-4, and uses therefor

0

US Patent 7105328 Methods for screening for compounds that modulate pd-1 signaling

0

US Patent 7122372 Peptide useful in immunomodulation

0

US Patent 7169791 Inhibitors of tyrosine kinases

0

...

Patent Primary Examiner

Ilia I Ouspenski

0

The present invention relates to methods of treating hematologic cancers using a combination of inhibitors of PD-1 or PD-L1 and TIM-3, LAG-3 or CTLA4.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11708412 Methods for treating hematologic cancers

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.